Abstract:Background In vivo monitoring of cell biodistribution using positron emission tomography (PET) provides a quantitative non-invasive method to further optimize cell therapies and related new developments in the field. Our group has earlier optimized and evaluated the in vitro properties of two radiotracers,[ 89 Zr]Zr-(oxinate) 4 and [ 89 Zr]Zr-DFO-NCS, for the radiolabelling of different cell types. Here, we performed a microPET study to assess the in vivo biodistribution of cells in rats using these two radiotracers. Human decidual stromal cells (hDSC) and rat macrophages (rMac) were radiolabelled with [ 89 Zr]Zr-(oxinate) 4 or [ 89 Zr]Zr-DFO-NCS. Rats were intravenously injected with radiolabelled cells, and the in vivo biodistribution was monitored with microPET/CT imaging for up to day 7. Organ uptake was evaluated and presented as a percentage of injected activity per gram tissue (%IA/g) and total absorbed organ doses (mSv/MBq). Results The biodistribution in vivo showed an immediate uptake in the lungs. Thereafter, [ 89 Zr]Zr-(oxinate) 4 labelled cells migrated to the liver, while the signal from [ 89 Zr]Zr-DFO-NCS labelled cells lingered in the lungs. The differences in the in vivo behaviour for the same cell type appeared related to the radiotracer labelling. After 24 h, [ 89 Zr]Zr-(oxinate) 4 labelled cells had over 70% higher liver uptake for both hDSC and rMac compared to [ 89 Zr]Zr-DFO-NCS labelled cells, whereas [ 89 Zr]Zr-DFO-NCS labelled cells showed over 60% higher uptake in the lungs compared to [ 89 Zr]Zr-(oxinate) 4 labelled cells. This difference in both lung and liver uptake continued until day 7. Dosimetry calculations showed a higher effective dose (mSv/MBq) for [ 89 Zr]Zr-DFO-NCS compared to [ 89 Zr]Zr-(oxinate) 4 , for both cell types. Although the bone uptake was higher for [ 89 Zr]Zr-(oxinate) 4 labelled cells, the prolonged uptake in the lungs contributed to a significant crossfire to bone marrow resulting in a higher bone dose. Conclusion The [ 89 Zr]Zr-DFO-NCS labelled cells suggest a prolonged accumulation in the lungs, while [ 89 Zr]Zr-(oxinate) 4 suggests quicker clearance of the lungs followed by accumulation in the liver. Accumulation of radiolabelled cells in the liver corresponds to other cell-tracking methods. Further studies are required to determine the actual location of the [ 89 Zr]Zr-DFO-NCS labelled cell.

Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with 89Zr Radioisotope in Mice and Rats

Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging

Quantitative Imaging Of Gd Nanoparticles In Mice Using Benchtop Cone-Beam X-Ray Fluorescence Computed Tomography System

Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99mTc-HMPAO

Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention.

Radioactive Labeling of Milk-Derived Exosomes with 99mTc and In Vivo Tracking by SPECT Imaging

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice

A Generic 89zr Labeling Method to Quantify the in Vivo Pharmacokinetics of Liposomal Nanoparticles with Positron Emission Tomography

Advances in Analysis of Biodistribution of Exosomes by Molecular Imaging

In vivo SPECT imaging of Tc-99m radiolabeled exosomes from human umbilical-cord derived mesenchymal stem cells in small animals

Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes

Repurposing Iron Chelators for Accurate Positron Emission Tomography Imaging Tracking of Radiometal‐labeled Cell Transplants

Xenogeneic Transplantation Promoted Human Exosome Sequestration in Rat Specific Organs

Exosome Heterogeneity Affects the Distal "Barrier-Crossing" Trafficking of Exosome Encapsulated Quantum Dots

Comparative in vivo biodistribution of cells labelled with [ 89 Zr]Zr-(oxinate) 4 or [ 89 Zr]Zr-DFO-NCS using PET

Fluorescent Chiral Quantum Dots to Unveil Origin-Dependent Exosome Uptake and Cargo Release

Comparative in vivo biodistribution of cells labelled with [Zr-89]Zr-(oxinate)(4) or [Zr-89]Zr-DFO-NCS using PET

Visualization and Identification of Bioorthogonally Labeled Exosome Proteins Following Systemic Administration in Mice

Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution in Vivo

Advances in imaging strategies for in vivo tracking of exosomes

Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells